Key Details
Annual ROE
-19.71%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Mar 24, 2023Recent annual earnings:
Mar 24, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
No data about analysts updates
Screeners with IMGO included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Imago BioSciences doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
FAQ
- What is the primary business of Imago BioSciences?
- What is the ticker symbol for Imago BioSciences?
- Does Imago BioSciences pay dividends?
- What sector is Imago BioSciences in?
- What industry is Imago BioSciences in?
- What country is Imago BioSciences based in?
- When did Imago BioSciences go public?
- Is Imago BioSciences in the S&P 500?
- Is Imago BioSciences in the NASDAQ 100?
- Is Imago BioSciences in the Dow Jones?
- When was Imago BioSciences's last earnings report?
- When does Imago BioSciences report earnings?
What is the primary business of Imago BioSciences?
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
What is the ticker symbol for Imago BioSciences?
The ticker symbol for Imago BioSciences is NASDAQ:IMGO
Does Imago BioSciences pay dividends?
No, Imago BioSciences does not pay dividends
What sector is Imago BioSciences in?
Imago BioSciences is in the Healthcare sector
What industry is Imago BioSciences in?
Imago BioSciences is in the Biotechnology industry
What country is Imago BioSciences based in?
Imago BioSciences is headquartered in United States
When did Imago BioSciences go public?
Imago BioSciences's initial public offering (IPO) was on 16 July 2021
Is Imago BioSciences in the S&P 500?
No, Imago BioSciences is not included in the S&P 500 index
Is Imago BioSciences in the NASDAQ 100?
No, Imago BioSciences is not included in the NASDAQ 100 index
Is Imago BioSciences in the Dow Jones?
No, Imago BioSciences is not included in the Dow Jones index
When was Imago BioSciences's last earnings report?
Imago BioSciences's most recent earnings report was on 24 March 2023
When does Imago BioSciences report earnings?
The date for Imago BioSciences's next earnings report has not been announced yet